Lineage, Inc. Common Stock (LINE)vsSTAG Industrial Inc (STAG)
LINE
Lineage, Inc. Common Stock
$37.75
+0.96%
REAL ESTATE · Cap: $9.50B
STAG
STAG Industrial Inc
$37.14
+0.73%
REAL ESTATE · Cap: $7.32B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 510% more annual revenue ($5.37B vs $880.59M). STAG leads profitability with a 28.1% profit margin vs -3.1%. STAG earns a higher WallStSmart Score of 56/100 (C).
LINE
Avoid35
out of 100
Grade: F
STAG
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
+54.4%
Fair Value
$86.08
Current Price
$37.14
$48.94 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Strong operational efficiency at 37.0%
Keeps 28 of every $100 in revenue as profit
Reasonable price relative to book value
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
Moderate valuation
3.3% earnings growth
ROE of 6.8% — below average capital efficiency
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : STAG
The strongest argument for STAG centers on Operating Margin, Profit Margin, Price/Book. Profitability is solid with margins at 28.1% and operating margin at 37.0%.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : STAG
The primary concerns for STAG are P/E Ratio, EPS Growth, Return on Equity.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while STAG is a mature play — different risk/reward profiles.
STAG carries more volatility with a beta of 0.96 — expect wider price swings.
STAG is growing revenue faster at 8.1% — sustainability is the question.
LINE generates stronger free cash flow (186M), providing more financial flexibility.
Bottom Line
STAG scores higher overall (56/100 vs 35/100), backed by strong 28.1% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →STAG Industrial Inc
REAL ESTATE · REIT - INDUSTRIAL · USA
STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant industrial properties throughout the United States.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?